Gastrointestinal Cancers and Clinical Trials: What Patients Need to Know Earlier On
-
By
-
May 20, 2026
-
9 min
Original Source(s)
Related Content
Turning Medical Insights into Patient Impact
Veeva research reveals a stark gap between the insights biopharma captures and the actions it takes – highlighting a missed opportunity to improve patient outcomes
May 21, 2026
-
6 min
Rethinking Progress in Clinical Trials
Three clinical development leaders discuss how early signals, trial design, regulatory expectations, and patient access are reshaping clinical development
May 20, 2026
-
11 min
Roswell Park Experts Report on Discovery of Rare Bladder Cells, Neural Mapping of Pelvic Floor Muscles at AUA 2026
Evidence provided by a Roswell Park study indicates that neoadjuvant chemotherapy may be the preferred course of treatment for patients with non-muscle-invasive bladder cancer (NMIBC) when their disease progresses and they are diagnosed with muscle-invasive bladder cancer (MIBC)
